Covered recipient · General Payments record
CHERYL ROBYN ROSENFELD
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$13,993.11
- Reported across 90 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,008.65 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc. | $250.38 | 2 |
| Amgen Inc. | $238.05 | 3 |
| ABBVIE INC. | $161.24 | 5 |
| Esperion Therapeutics, Inc. | $124.73 | 1 |
| Acerta Pharma LLC | $120.29 | 1 |
| Corcept Therapeutics | $113.96 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $120.29 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105976280 | CMS |
| ABBVIE INC. | $6.82 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105976282 | CMS |
| ABBVIE INC. | $11.75 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105976284 | CMS |
| ABBVIE INC. | $13.58 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105976286 | CMS |
| ABBVIE INC. | $8.80 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105976288 | CMS |
| Amgen Inc. | $124.73 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111692402 | CMS |
| Amgen Inc. | $16.77 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111692398 | CMS |
| Amgen Inc. | $96.55 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111692400 | CMS |
| AstraZeneca Pharmaceuticals LP | $120.29 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105762558 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $124.73 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086170384 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $125.65 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086126614 | CMS |
| Corcept Therapeutics | $113.96 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117777828 | CMS |
| Esperion Therapeutics, Inc. | $124.73 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129452970 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.